Skip to main content
logo
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.175
+0.045 (2.11%)
At close: May 22, 2026, 4:00 PM EDT
2.190
+0.015 (0.69%)
After-hours: May 22, 2026, 4:10 PM EDT

Aytu BioPharma Revenue

Aytu BioPharma had revenue of $12.41M in the quarter ending March 31, 2026, a decrease of -32.74%. This brings the company's revenue in the last twelve months to $56.60M, down -14.04% year-over-year. In the fiscal year ending June 30, 2025, Aytu BioPharma had annual revenue of $66.38M with 1.84% growth.

Revenue (ttm)
$56.60M
Revenue Growth
-14.04%
P/S Ratio
0.42
Revenue / Employee
$681,916
Employees
83
Market Cap
23.51M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202566.38M1.20M1.84%
Jun 30, 202465.18M-42.22M-39.31%
Jun 30, 2023107.40M10.73M11.10%
Jun 30, 202296.67M31.04M47.29%
Jun 30, 202165.63M38.00M137.52%
Jun 30, 202027.63M--
Jun 30, 2019---
Jun 30, 20183.66M-2.78M-43.19%
Jun 30, 20176.44M--
Jun 30, 2016---
Jun 30, 2015261.78K260.78K26,078.20%
Aug 31, 20141,000.00-57.93K-98.30%
Jun 30, 201458.93K57.18K3,267.37%
Aug 31, 20131.75K-48.25K-96.50%
Jun 30, 201350.00K48.25K2,757.14%
Aug 31, 20121.75K--
Aug 31, 2011---
Aug 31, 2010---
Aug 31, 20091.75K--
Aug 31, 2008---
Aug 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
InterCure84.76M
Rockwell Medical67.68M
Zhengye Biotechnology Holding16.64M
China Pharma Holdings3.99M
TherapeuticsMD3.35M
China SXT Pharmaceuticals1.54M
Akanda836.66K
BioXcel Therapeutics680.00K
Revenue Rankings

AYTU News

More News